NewsBenzingaGuardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH Benzinga 2026.10.08 20:14 (GMT+0) Open on Benzinga Other news ARGX Stock Sinks as Argenx Scraps Late-Stage Trial Pretend you’re sitting at Elizabeth Holmes’ desk on this weirdly detailed website AVGO Stock Alert: What to Know About Broadcom's $50 Billion Financing Deal for OpenAI Chips CMG Stock Pops on Reports Starbucks Considered Chipotle Takeover Broader Market Settles Lower on Soaring Crude Prices and Chipmaker Weakness A $2 Billion Reason Why GlobalFoundries Stock Is Up Today
